CB Therapeutics

Growth Stage
Advanced synthetic biology for planet and human health
Overview
Raised: $10,650
Rolling Commitments ($USD)
Status
Active
Reporting Date
03/27/2023
Days Remaining
34
% of Min. Goal
43%
% of Max. Goal
1%
Likelihood of Max
Avg. Daily Raise
$394
# of Investors
32
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2015
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
CB Therapeutics, with a valuation of $45 million, is raising funds on Republic. The company has developed an advanced synthetic biology and cellular agriculture platform. The platform aims to discover, develop, and produce compounds to solve problems in the field of healthcare, food, mental health, and the environment. CB Therapeutics has a substantial patent portfolio with seven granted and 13 pending patents and has been generating revenues since 2022. She Ali Butt and Jacob Vogan founded CB Therapeutics in March 2015. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $1.24 million. The campaign proceeds will be used for small-scale manufacturing, hiring of laboratory personnel, and research and development.
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$2,014,066 |
$0 |
COGS |
$0 |
$0 |
Tax |
$3,017 |
$1,600 |
| ||
| ||
Net Income |
$-1,772,158 |
$-2,278,343 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$1,810,709 |
$13,453 |
Accounts Receivable |
$14,066 |
$0 |
Total Assets |
$3,722,376 |
$910,015 |
Short-Term Debt |
$287,110 |
$677,795 |
Long-Term Debt |
$188,555 |
$730,988 |
Total Liabilities |
$475,665 |
$1,408,783 |
Financials as of: 02/28/2023
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Wall Street has Morningstar, S&P, and Bloomberg
The equity crowdfunding market has KingsCrowd.
Are you the founder of CB Therapeutics? Create your account today to claim this raise page.